Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Malkowicz

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Nature|February 3, 1994
Urothelial carcinogenesisA J Linnenbach, S L Robbins, B A Seng, et al.
International Journal of Impotence Research|September 26, 2000
Erectile function and quality of life after interstitial radiation therapy for prostate cancerR F Sánchez-Ortiz, G A Broderick, E S Rovner, et al.
American Journal of Clinical Oncology|June 19, 2001
Phase II trial of toremifene in androgen-independent prostate cancer: a Penn cancer clinical trials group trialS Stein, B Zoltick, T Peacock, et al.
Human Molecular Genetics|September 1, 1993
Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assayA J Linnenbach, L B Pressler, B A Seng, et al.
The Journal of Urology|November 17, 1998
The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Urology|April 1, 1997
Development of prostate cancer after pituitary dysfunction: a report of 8 patientsD W Ebling, J Ruffer, R Whittington, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 1999
Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancerT R Rebbeck, A H Walker, J M Jaffe, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 1997
The use of combined radiation therapy and hormonal therapy in the management of lymph node-positive prostate cancerR Whittington, S B Malkowicz, M Machtay, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 1997
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/mlA V D'Amico, R Whittington, I Kaplan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 1994
A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Nature|February 3, 1994
Urothelial carcinogenesisA J Linnenbach, S L Robbins, B A Seng, et al.
International Journal of Impotence Research|September 26, 2000
Erectile function and quality of life after interstitial radiation therapy for prostate cancerR F Sánchez-Ortiz, G A Broderick, E S Rovner, et al.
American Journal of Clinical Oncology|June 19, 2001
Phase II trial of toremifene in androgen-independent prostate cancer: a Penn cancer clinical trials group trialS Stein, B Zoltick, T Peacock, et al.
Human Molecular Genetics|September 1, 1993
Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assayA J Linnenbach, L B Pressler, B A Seng, et al.
The Journal of Urology|November 17, 1998
The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Urology|April 1, 1997
Development of prostate cancer after pituitary dysfunction: a report of 8 patientsD W Ebling, J Ruffer, R Whittington, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 1999
Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancerT R Rebbeck, A H Walker, J M Jaffe, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 1997
The use of combined radiation therapy and hormonal therapy in the management of lymph node-positive prostate cancerR Whittington, S B Malkowicz, M Machtay, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 1997
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/mlA V D'Amico, R Whittington, I Kaplan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 1994
A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Pageof 12